• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH ARCHITECT HIV AG/AB COMBO REAGENT KIT; TEST, HIV DETECTION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH ARCHITECT HIV AG/AB COMBO REAGENT KIT; TEST, HIV DETECTION Back to Search Results
Catalog Number 04J27-37
Device Problem Leak/Splash (1354)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/03/2023
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.All available patient information was included.Additional patient details are not available.This report is being filed on an international product, list number 04j27-37, that has a similar product distributed in the us, list number 02p36.
 
Event Description
The customer reported that while preparing the hiv ag/ab combo control material, they noticed a few drops of control material splashed on their face.The customer washed their face with plenty of water.The customer did not receive any treatment for the exposure.It was noted that the customer will be tested for hiv ag/ab once a week.There was no adverse impact to the user reported.
 
Manufacturer Narrative
The complaint investigation for architect hiv ag/ab combo quality control exposure included a review of information provided by the customer, a search for similar complaints, ticket trending review, labeling review, and device history record review.While preparing the hiv ag/ab combo control material, they noticed a few drops of control material splashed on their face.The customer washed their face with plenty of water.The customer did not receive any treatment for the exposure.No subsequent issues have been reported.Device history record review did not identify any non-conformances or deviations with the likely cause lot and complaint issue.Manufacturing documentation for the likely cause lot was reviewed and did not identify any issues.Labeling was reviewed and sufficiently addresses the issue.Based on the information provided and abbott diagnostics¿ complaint investigation, the architect hiv ag/ab combo is performing as intended at the customer site, and no systemic issue or deficiency was identified.Concomitant product section updated to correct the hiv control lot number.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT HIV AG/AB COMBO REAGENT KIT
Type of Device
TEST, HIV DETECTION
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
Manufacturer (Section G)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM   65205
Manufacturer Contact
siobhan wright
lisnamuck
post market surveillance
longford N39 E-932
EI   N39 E932
433331157
MDR Report Key16368778
MDR Text Key309521554
Report Number3002809144-2023-00085
Device Sequence Number1
Product Code MZF
Combination Product (y/n)N
Reporter Country CodeTU
PMA/PMN Number
N/A
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 03/29/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/13/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/31/2023
Device Catalogue Number04J27-37
Device Lot Number43120BE00
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/28/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/14/2022
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARC HIV AG/AB CTL, 04J27-12, 40378BE00.; ARC I2000SR INST, 03M74-02, (B)(4).; ARC I2000SR INST, 03M74-02, (B)(4).; HIV AG/AB CMB CTL, 06L24-10, 46400BE00.
-
-